Skip to main content

Month: March 2026

Kratos, Airbus Preparing Two Valkyries for First Flight with European Mission System

Joint Team Continues to Progress Towards Completing an Integrated Uncrewed Collaborative Combat Aircraft (UCCA) System for the German Air Force SAN DIEGO, March 13, 2026 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a leader in defense, national security and global markets, and its partner Airbus announced today that the joint team continues to take steps towards completing an integrated Uncrewed Collaborative Combat Aircraft (UCCA) offering for the German Air Force and towards a maiden flight with a sovereign European mission system, the Multiplatform Autonomous Reconfigurable and Secure (MARS) system. The two companies are bringing their respective industry-leading capabilities to integrate, missionize, and ultimately produce and deliver the Airbus UCCA System and are scheduled to fly later...

Continue reading

XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote “For” the Share Consolidation

Your vote is important – Vote well in advance of the proxy voting deadline: March 20, 2026 XORTX’s board of directors unanimously recommends that Shareholders vote FOR all resolutions Shareholder questions or need voting assistance? Please contact Laurel Hill Advisory Group by email at assistance@laurelhill.com, or by texting “INFO” to, or calling, 1-877-452-7184 (North American toll-free) or 1-416-304-0211 (outside North America).CALGARY, Alberta, March 13, 2026 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, is pleased to announce that independent proxy advisory firms, including Institutional Shareholder Services...

Continue reading

illumin Reports Fourth Quarter and Full Year 2025 Financial Results

Fourth Quarter Revenue Reaches $43.1 MillionExchange Service Revenue Up 48% YoYSelf Service Revenue Up 23% Sequentially Entering 2026 With Improved Operating Structure (All monetary figures are expressed in thousands of Canadian dollars unless otherwise stated) TORONTO, March 13, 2026 (GLOBE NEWSWIRE) — illumin Holdings Inc. (TSX: ILLM) (OTCQB: ILLMF) (“illumin” or “Company”), a leader in digital advertising technology that empowers marketers to make smarter decisions about communicating with online consumers, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 HighlightsRevenue was $43.1 million, compared to $49.9 million in the year ago period. Exchange service revenue increased by 48% year-over-year to $19.7 million, representing 46% of total revenue. Self...

Continue reading

G-III Apparel Group Declares Quarterly Dividend

NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) — G-III Apparel Group, Ltd. (NASDAQ: GIII) today announced that its Board of Directors has declared a quarterly cash dividend of $0.10 per share. The dividend is payable on March 30, 2026 to stockholders of record on March 23, 2026. About G-III Apparel Group, Ltd.  G-III Apparel Group, Ltd. is a global fashion leader with expertise in design, sourcing, distribution, and marketing. The Company owns and licenses a portfolio of more than 30 preeminent brands, each differentiated by unique brand propositions, product categories, and consumer touchpoints. G-III owns ten iconic brands, including DKNY, Donna Karan, Karl Lagerfeld, and Vilebrequin, and licenses over 20 of the most sought-after names in global fashion, including Calvin Klein, Tommy Hilfiger, Levi’s, Nautica, Halston, Champion, Converse,...

Continue reading

StorageVault Announces Quarterly Dividend for Q1 2026

TORONTO, March 13, 2026 (GLOBE NEWSWIRE) — STORAGEVAULT CANADA INC. (“StorageVault” or the “Corporation”) (SVI-TSX announced today that a quarterly dividend of $0.003006 per common share (“Common Share”) ‎will be payable on ‎April 15, 2026 to shareholders of record on March 31, 2026, with an ex-dividend ‎date of March 31, 2026. This dividend has been designated as an “eligible dividend” for Canadian ‎income tax ‎purposes.‎ ‎ About StorageVault Canada Inc.StorageVault currently owns and operates 265 storage locations across Canada. StorageVault owns 232 of these locations plus over 5,000 portable storage units representing over 13.2 million rentable square feet on 768 acres of land. StorageVault also provides last mile storage and logistics’ solutions and professional records management services, ‎such as document and media storage,...

Continue reading

Waldencast Reports Q4 2025 and FY 2025 Financial Results

FY 2025 net revenue of $272.1 million, flat to FY 2024, and Adjusted EBITDA of $16.1 million Q4 2025 net revenue of $72.0 million, flat to Q4 2024 and Adjusted EBITDA of $6.6 million Obagi Medical sees continued revenue acceleration as a result of transformation efforts and continued brand momentum, alongside investments supporting the recent launch of its injectables platform Milk Makeup maintains U.S. consumption growth through distribution expansion, offset by softness in international markets Waldencast advanced its strategic priorities in 2025, entering medical aesthetics, and strengthening its financial flexibility through the sale of the Obagi Japan trademark and the refinancing of its credit facility. As a result, the Company enters 2026 with a strong foundation for successful growth LONDON, March 13, 2026 (GLOBE NEWSWIRE) —...

Continue reading

Form 8.3 – [IDOX PLC – 12 03 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDOX PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDOX PLC AS AN ASSOCIATE OF THE CANACCORD...

Continue reading

Picard Medical / SynCardia Highlight Total Artificial Heart on BTV Program Airing on FOX Business News

Segment showcases SynCardia Total Artificial Heart supporting patients with advanced heart failure and next-generation development programs TUCSON, Ariz., March 13, 2026 (GLOBE NEWSWIRE) — Picard Medical, Inc. (NYSE American: PMI) (the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that the SynCardia Total Artificial Heart (“STAH”) will be featured in an upcoming segment on BTV Business Television airing on the FOX Business News on Saturday, March 14 at 5:00 p.m. EST. The segment will highlight the Company artificial heart technology designed to replace the pumping function of a failing human heart during the time that a patient awaits transplantation. With more than 2,100 implants performed worldwide, the STAH...

Continue reading

AMC Robotics and HIVE Announce Collaboration to Advance AI-Driven Robotics Compute Infrastructure

NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) — AMC Robotics Corporation (Nasdaq: AMCI) (“AMC Robotics” or the “Company”), an AI-driven robotics solutions provider, and HIVE Digital Technologies (“HIVE”) (TSX.V: HIVE) (Nasdaq: HIVE) (FSE: YO0) (BVC: HIVECO), a global leader in sustainable digital infrastructure and AI compute, today jointly announced a strategic collaboration focused on advancing next-generation AI-driven robotics applications and scalable infrastructure capabilities. Through this collaboration, AMC Robotics has begun utilizing HIVE’s GPU AI compute infrastructure and related services to support the Company’s expanding development, testing, and deployment needs. In parallel, the two companies are actively exploring broader areas of cooperation, including potential collaboration across AI optimization, data processing,...

Continue reading

Voyager Acquisition Corporation Announces Approval of Its Business Combination with Veraxa Biotech AG

BROOKLYN, N.Y., March 13, 2026 (GLOBE NEWSWIRE) — Voyager Acquisition Corporation (NASDAQ: “VACHU,” “VACH,” “VACHW”) (“Voyager” or the “Company”) held the general meeting on March 12, 2026 and approved the previously announced business combination (the “Business Combination”) with VERAXA Biotech AG (“VERAXA”). After the closing of the Business Combination, it is expected that the combined company will trade on Nasdaq under the new symbol (“VRXA”). As previously announced, holders of 25,217,315 of the Company’s Class A ordinary shares (“Class A shares”) exercised their right to redeem their shares for a pro rata portion of the funds in the Company’s trust account, reflecting redemptions of approximately 99.67% of the total Class A shares outstanding in connection with the completion of the Business Combination pursuant...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.